Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ...

Vyne Therapeutics has dosed the first participant in a randomised Phase Ib clinical trial of VYN202, an oral treatment for moderate-to-severe plaque psoriasis. The double-blind, placebo-controlled ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa in 7 specific patient populations.

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...